Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis

The obesity epidemic is a global concern nowadays since obesity is a major risk factor that can cause many serious diseases. A high risk of developing diseases in an obese person primarily occurs due to metabolic disorders. As a rule, dyslipidemia acts as an early sign of metabolic disorders in case...

Full description

Bibliographic Details
Main Authors: A.M. Kaneva, E.R. Bojko
Format: Article
Language:English
Published: FBSI “Federal Scientific Center for Medical and Preventive Health Risk Management Technologies” 2022-09-01
Series:Analiz Riska Zdorovʹû
Subjects:
Online Access:https://journal.fcrisk.ru/eng/2022/3/15
_version_ 1811303550596153344
author A.M. Kaneva
E.R. Bojko
author_facet A.M. Kaneva
E.R. Bojko
author_sort A.M. Kaneva
collection DOAJ
description The obesity epidemic is a global concern nowadays since obesity is a major risk factor that can cause many serious diseases. A high risk of developing diseases in an obese person primarily occurs due to metabolic disorders. As a rule, dyslipidemia acts as an early sign of metabolic disorders in case of obesity. Our research goal was to compare informative value of body mass index (BMI) and lipid accumulation product (LAP) for assessing atherogenic risks in lipid profile. Two thousand and four hundred people aged 20–60 years took part in our study. We determined participants’ anthropometric and clinical indicators and estimated lipid levels in blood serum. As expected, LAP values had a strong correlation with BMI values. Spearman’s rank correlation coefficient for LAP and BMI values amounted to 0.73 (< 0.001) in men (n = 1168) and 0.77 (< 0.001) in women (n = 1232). However, when we estimated agreement between these two indicators using Cohen’s Kappa coefficient, we established that this agreement between LAP and BMI values was rather low (0.35 for men and 0.39 for women). Having compared samplings with quartiles that differed as per LAP and BMI values, we detected that lipid profiles tended to be more atherogenic in people with LAP values being higher than BMI values. Given this established discordance in the quartiles, higher LAP values are associated with atherogenicity of lipid profile to a greater extent than values of BMI, the conventional obesity indicator. Using solely BMI to diagnose obesity may result in underestimating metabolic disorders in the body. To assess obesity and metabolic health correctly, it is advisable to determine LAP value together with traditional obesity indexes.
first_indexed 2024-04-13T07:48:49Z
format Article
id doaj.art-377e7efe638d4a92a524b12cfda94415
institution Directory Open Access Journal
issn 2308-1155
2308-1163
language English
last_indexed 2024-04-13T07:48:49Z
publishDate 2022-09-01
publisher FBSI “Federal Scientific Center for Medical and Preventive Health Risk Management Technologies”
record_format Article
series Analiz Riska Zdorovʹû
spelling doaj.art-377e7efe638d4a92a524b12cfda944152022-12-22T02:55:35ZengFBSI “Federal Scientific Center for Medical and Preventive Health Risk Management Technologies”Analiz Riska Zdorovʹû2308-11552308-11632022-09-01316016710.21668/health.risk/2022.3.15.engInformative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysisA.M. Kaneva0E.R. Bojko1Institute of Physiology of Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences, FRC Коmi SC UB RAS, 50 Pervomayskaya Str., Syktyvkar, Komi Republic, 167982, Russian FederationInstitute of Physiology of Коmi Science Centre of the Ural Branch of the Russian Academy of Sciences, FRC Коmi SC UB RAS, 50 Pervomayskaya Str., Syktyvkar, Komi Republic, 167982, Russian FederationThe obesity epidemic is a global concern nowadays since obesity is a major risk factor that can cause many serious diseases. A high risk of developing diseases in an obese person primarily occurs due to metabolic disorders. As a rule, dyslipidemia acts as an early sign of metabolic disorders in case of obesity. Our research goal was to compare informative value of body mass index (BMI) and lipid accumulation product (LAP) for assessing atherogenic risks in lipid profile. Two thousand and four hundred people aged 20–60 years took part in our study. We determined participants’ anthropometric and clinical indicators and estimated lipid levels in blood serum. As expected, LAP values had a strong correlation with BMI values. Spearman’s rank correlation coefficient for LAP and BMI values amounted to 0.73 (< 0.001) in men (n = 1168) and 0.77 (< 0.001) in women (n = 1232). However, when we estimated agreement between these two indicators using Cohen’s Kappa coefficient, we established that this agreement between LAP and BMI values was rather low (0.35 for men and 0.39 for women). Having compared samplings with quartiles that differed as per LAP and BMI values, we detected that lipid profiles tended to be more atherogenic in people with LAP values being higher than BMI values. Given this established discordance in the quartiles, higher LAP values are associated with atherogenicity of lipid profile to a greater extent than values of BMI, the conventional obesity indicator. Using solely BMI to diagnose obesity may result in underestimating metabolic disorders in the body. To assess obesity and metabolic health correctly, it is advisable to determine LAP value together with traditional obesity indexes. https://journal.fcrisk.ru/eng/2022/3/15lipid accumulation product (lap)body mass index (bmi)obesitymarkerswaist circumferencetriglyceridesatherogenicitymetabolism
spellingShingle A.M. Kaneva
E.R. Bojko
Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis
Analiz Riska Zdorovʹû
lipid accumulation product (lap)
body mass index (bmi)
obesity
markers
waist circumference
triglycerides
atherogenicity
metabolism
title Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis
title_full Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis
title_fullStr Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis
title_full_unstemmed Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis
title_short Informative value of two obesity markers, body mass index (BMI) and lipid accumulation product (LAP), for assessing atherogenic risks in lipid profile: comparative analysis
title_sort informative value of two obesity markers body mass index bmi and lipid accumulation product lap for assessing atherogenic risks in lipid profile comparative analysis
topic lipid accumulation product (lap)
body mass index (bmi)
obesity
markers
waist circumference
triglycerides
atherogenicity
metabolism
url https://journal.fcrisk.ru/eng/2022/3/15
work_keys_str_mv AT amkaneva informativevalueoftwoobesitymarkersbodymassindexbmiandlipidaccumulationproductlapforassessingatherogenicrisksinlipidprofilecomparativeanalysis
AT erbojko informativevalueoftwoobesitymarkersbodymassindexbmiandlipidaccumulationproductlapforassessingatherogenicrisksinlipidprofilecomparativeanalysis